Orient Pharma Co., Ltd. Yunlin Plant recalls
FDA enforcement reports naming Orient Pharma Co., Ltd. Yunlin Plant as the recalling firm.
- Recall reports
- 2
- Class I (serious)
- 0
- Most recent report
- Jul 9, 2025
- Jul 9, 2025Pitavastatin Tablets, 2 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma CoDrug · Orient Pharma Co., Ltd. Yunlin PlantFailed Impurities/Degradation Specifications.Class III
- Jul 9, 2025Pitavastatin Tablets, 1 mg, Rx Only, 90 Tablets, Manufactured by: Orient Pharma CoDrug · Orient Pharma Co., Ltd. Yunlin PlantFailed Impurities/Degradation Specifications.Class III